However, tirzepatide is also currently in shortageaccess may ultimately depend on whats available in your area
For mothers using formula feeding, resuming semaglutide injections a few weeks after delivery is generally considered safe, though individual timing should be discussed with your OB-GYN
For a medicine to receive UK marketing authorisation, the manufacturer must submit a comprehensive dossier of evidence including Phase 3 clinical trial data demonstrating that the product meets the required standards of safety, efficacy, and quality
This is why weight loss is the most evidence-based non-surgical intervention for knee OA
This points to disturbingly high levels of societal stigma and bias towards those living with obesity
It also aligns with the observed improvements in cardiometabolic markers seen in clinical trials of incretin-based therapies